---
title: "FDA authorizes Moderna's mRNA flu vaccine after public pressure, initially rejected application review."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295046088.md"
description: "Initially, the agency declined to review the application, but they later changed their decision due to public pressure."
datetime: "2026-08-06T02:26:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295046088.md)
  - [en](https://longbridge.com/en/news/295046088.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295046088.md)
generator: "portal-rs"
---

# FDA authorizes Moderna's mRNA flu vaccine after public pressure, initially rejected application review.

Initially, the agency declined to review the application, but they later changed their decision due to public pressure.

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md)

## Related News & Research

- [Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test](https://longbridge.com/en/news/296382081.md)
- [Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.](https://longbridge.com/en/news/296643850.md)
- [Wolfe Research Just Upgraded Moderna Stock. Here's Why.](https://longbridge.com/en/news/296951590.md)
- [Moderna stock soars on cancer vaccine success](https://longbridge.com/en/news/296405393.md)
- [If You Invested $1,000 In Moderna Stock at IPO, Here's How Much You'd Have Now](https://longbridge.com/en/news/296641626.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**